Verana Health – Pioneering Digital Health through Quality Data

Verana Health is a digital health company that delivers quality drug lifecycle, medical practice, and medical society insights from an exclusive real-world data network of more than 20,000 healthcare providers. Its specialty medical society partners entrust it to manage data from this network ─ nearly a half-billion, de-identified healthcare encounters ─ feeding it through the population health data engine, VeraQ^™, to produce quality, disease-specific data sets, Qdata^™. VeraQ and Qdata power the data analytics Verana Health conducts for Life Sciences–including for the top 4 of 5 pharmaceutical companies–and certain value-added services it offers healthcare providers in its network, such as MIPS quality reporting.

Who Verana Health Serves

Life Sciences: Verana Health collaborates with the top, multinational pharmaceutical companies as well as emerging biotechnology and biopharmaceutical companies. They conduct clinical research and business analytics at each stage of the drug or device life cycle. They derive meaningful insights in the early stages of clinical development and pre-approval through to post-approval and commercialization.

Contract Research Organizations: Verana Health enables CROs to round out offerings and capabilities for clinical trial enablement by leveraging their robust real-world data network and insights for study design, protocol optimization, site identification, and trial recruitment.

Healthcare Providers: Verana Health powers a trusted real-world data network of more than 20,000 providers. Medical practices contribute their de-identified data by participating in a medical registry of one of Verana Health’s medical society partners. Participating practices benefit from value-added services, such as MIPS quality reporting for select providers, clinical trial opportunities, and more.

Specialty Medical Societies: Verana Health is the exclusive data partner of the American Academy of Ophthalmology, American Urological Association, and American Academy of Neurology. They manage data end-to-end, from ingestion into a medical registry to harmonization of 70+ electronic health records to analysis that powers quality reporting, clinical research, and industry insights.

VeraQ^®: Verana Health’s Population Health Data Engine

Advance the quality of insights to inform clinical research with VeraQ^® by Verana Health^®, a population health data engine that connects the dots across unfiltered healthcare data. VeraQ is clinician-directed and enhanced by artificial intelligence (AI) to securely power a data integrity feedback loop of nearly a half-billion raw, point-of-care health encounters. Anchored in clinician connectedness, VeraQ by Verana Health is the foundation for quality insights across clinical research. Its data stem from an exclusive and trustworthy real-world data network and its science-first methodology for processing and analyzing data drive integrity in real-world evidence. Data curated by VeraQ are clinically true Qdata^®—disease-specific, fit-for-purpose data modules designed to confidently drive business insights and rigorously inform research outcomes. VeraQ and Qdata are the backbone of a multitude of observational research studies in ophthalmology, urology, and neurology, helping to unlock quality research insights along the entire drug and medical device development lifecycle.

How VeraQ Works

The VeraQ engine is powered by electronic health record (EHR) data that are exclusively entrusted to Verana Health by specialty medical societies: the American Academy of Ophthalmology, American Academy of Neurology, and American Urological Association. VeraQ ingests, links, and curates data to enable trusted observational research stemming from real-world healthcare data.

 The result? Quality insights to accelerate medical innovations that promote quality of care for clinicians and quality of life for patients.

Qdata^®: Curated, Clinically True Data Modules to Power Research

Qdata^® by Verana Health are fit-for-purpose data modules designed to confidently drive business insights and rigorously inform research outcomes. Qdata spans three therapeutic areas—ophthalmology, neurology, and urology—and reflects deep patient journeys across robust demographics. Qdata helps to unlock quality research insights along the entire drug and medical device development lifecycle, from clinical trial site and patient identification to market tracking. Qdata modules are curated data sets ready for research use to inform real-world evidence (RWE). Qdata is powered by Verana Health’s population health data engine, VeraQ^®, which contains rich medical specialty data exclusively found here. Qdata modules are available for analysis via Verana Health analytics services. Select modules are also available via regularly refreshed dashboards and direct data access. Thanks to VeraQ’s NLP-guided curation coupled with the human touch of physician-informed context, millions of records with free-form text become meaningful and can be distilled into usable and valuable Qdata variables.

How Qdata Works

Qdata stems from more than seven years of real-world data contributed by more than 20,000 healthcare providers across ophthalmology, urology, and neurology. The data modules start with structured and unstructured electronic health records (EHRs) from more than 90 million de-identified patients and 70 EHR systems. Then, data are harmonized, tokenized, and linked with other sources, such as claims and images in Verana Health’s VeraQ engine.

Finally, the data are curated with a clinician-first approach, complemented by natural language processing (NLP) and machine learning. The result is Qdata: research ready data to enable observational studies on a multitude of diseases.

Meet the Visionary Leader Upfront

Sujay Jadhav is the Chief Executive Officer at Verana Health. He is helping to accelerate the company’s growth and sustainability by advancing clinical trial capabilities, data-as-a-service offerings, medical society partnerships, and data enrichment.

Sujay joins Verana Health with more than 20 years of experience as a seasoned executive, entrepreneur, and global business leader. Most recently, Sujay was the Global Vice President, Health Sciences Business Unit at Oracle, where he ran the organization’s entire product and engineering teams. Before Oracle, Sujay was the CEO of cloud-based clinical research platform goBalto, where he oversaw the acquisition of the company by Oracle. Sujay is also a former executive for life sciences technology company Model N, where he helped to oversee its transition to a public company.

Mr. Jadhav holds an MBA from Harvard University and a bachelor’s degree in electronic engineering from the University of South Australia.

"Verana Health sits at the center of a healthcare data ecosystem, helping enable clinical researchers, life science analysts, and healthcare providers to accelerate medical innovations."